Ascentage Pharma Group (AAPG) (AAPGV) (ASPHF), which is backed by Takeda (TAK), has priced a $126M U.S. initial public offering. Read more here.

Ascentage Pharma Group Corp. Ltd. has priced the first IPO of the year in the U.S. The offering of 7.32 million shares has the Suzhou, China, and Rockville, Md.-based company looking for gross ...

Ascentage Pharma Hogan.Wan@ascentage.com +86 512 85557777 Stephanie Carrington ICR Healthcare Stephanie.Carrington@icrhealthcare.com (646) 277-1282 Media Relations Sean Leous ICR Healthcare ...

Ascentage Pharma Hogan.Wan@ascentage.com +86 512 85557777 Stephanie Carrington ICR Healthcare Stephanie.Carrington@icrhealthcare.com +1 (646) 277-1282 Media Relations: Sean Leous ICR Healthcare ...

Ascentage Pharma Group International had issued 7,325,000 shares in its initial public offering on January 24th. The total size of the offering was $126,356,250 based on an initial share price of ...

These are the ceremonies for January 2025. Market opening and closing ceremonies take place on weekdays at the Nasdaq MarketSite Studio in Times Square and around the globe. Ascentage Pharma Group ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Ascentage Pharma Group Internat (NASDAQ:AAPG) stands against ...

JP Morgan sees strong growth for Ascentage Pharma, citing its late-stage cancer drugs. The biotech's 2024 sales surged 342% YoY, driven by a Takeda payment.

Ascentage Pharma Rings the Opening Bell 0 of 17 minutes, 0Volume 0% ... January 24, 2025 — 9:15 AM - 9:45 AM ET Nasdaq MarketSite, 4 Times Square, New York ...